This is a StreetInsider.com Premium Only Page

Sagent Pharmaceuticals (SGNT) –

Feb 22, 2023 04:48 PM LatticeFlow AG Appoints Global Technology Executive, Andre Boisvert, As Chairman of The Board

Jul 20, 2017 05:04 PM Aeterna Zentaris (AEZS) Forms Committee to Consider Strategic and Financing Alternatives; Michael Ward Named as New CEO, Replacing David A. Dodd

Jul 20, 2017 05:00 PM Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO

Feb 14, 2017 07:01 AM Form SC 13G/A Sagent Pharmaceuticals, Filed by: HealthCor Management, L.P.

Sep 9, 2016 09:06 AM Form 15-12B Sagent Pharmaceuticals,

Sep 6, 2016 06:01 AM Form EFFECT Sagent Pharmaceuticals,

Sep 2, 2016 03:30 PM Form SC 13G/A Sagent Pharmaceuticals, Filed by: Vivo Ventures V, LLC

Sep 1, 2016 06:03 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: Vivo Ventures Fund V, L.P.

Sep 1, 2016 06:01 PM Form 4 Sagent Pharmaceuticals, For: Apr 21 Filed by: Vivo Ventures VI, LLC

Aug 31, 2016 06:26 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: Singer Jonathon M

Aug 31, 2016 06:25 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: OBERMAN ALLAN

Aug 31, 2016 06:24 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: BULLOCK DONALD R

Aug 31, 2016 06:24 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: Krizman Anthony

Aug 31, 2016 06:24 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: Behrens Mary Taylor

Aug 31, 2016 06:23 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: FLANAGAN ROBERT J

Aug 31, 2016 06:22 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: BRYNJELSEN SEAN

Aug 31, 2016 06:21 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: WARD MICHAEL V.

Aug 31, 2016 06:21 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: FEKETE MICHAEL

Aug 31, 2016 06:19 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: Harmon J Frank

Aug 31, 2016 06:12 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: Yanai Shlomo

Aug 31, 2016 06:12 PM Form 4 Sagent Pharmaceuticals, For: Aug 29 Filed by: Greve Jeffrey W.

Aug 30, 2016 02:56 PM Form S-8 POS Sagent Pharmaceuticals,

Aug 30, 2016 02:51 PM Form POS AM Sagent Pharmaceuticals,

Aug 29, 2016 04:17 PM Form 8-K Sagent Pharmaceuticals, For: Aug 29

Aug 29, 2016 04:12 PM Form SC 14D9/A Sagent Pharmaceuticals, Filed by: Sagent Pharmaceuticals, Inc.

Aug 29, 2016 01:17 PM Form 25-NSE Sagent Pharmaceuticals, Filed by: NASDAQ Stock Market LLC

Aug 29, 2016 07:58 AM Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stock of Sagent Pharmaceuticals, Inc.

Aug 29, 2016 06:16 AM Form SC TO-T/A Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Aug 24, 2016 09:23 AM Form SC TO-T/A Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Aug 23, 2016 09:21 AM Pre-Open Stock Movers 08/23: (STML) (BBY) (DATA) (MBLY) Higher; (SPHS) (TKAI) (ZOES) Lower (more...)

Aug 22, 2016 05:51 PM Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600

Aug 22, 2016 05:47 PM After-Hours Stock Movers 08/22: (DATA) (SCVL) (CHFC) Higher; (SPHS) (TKAI) (ZOES) Lower (more...)

Aug 22, 2016 05:38 PM Chemical Financial (CHFC) Set to Join S&P MidCap 400; Supervalu (SVU), Shoe Carnival (SCVL) and Eagle Pharmaceuticals (EGRX) to Join S&P SmallCap 600

Aug 22, 2016 06:08 AM Form SC TO-T/A Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Aug 18, 2016 04:56 PM Form SC TO-T/A Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Aug 18, 2016 04:39 PM Form SC 14D9/A Sagent Pharmaceuticals, Filed by: Sagent Pharmaceuticals, Inc.

Aug 17, 2016 05:45 PM Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10 g due to presence of iron oxide particulate matter

Aug 12, 2016 05:26 PM Form SC TO-T/A Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Aug 12, 2016 05:14 PM Form SC 14D9/A Sagent Pharmaceuticals, Filed by: Sagent Pharmaceuticals, Inc.

Aug 9, 2016 05:10 PM Form SC 14D9/A Sagent Pharmaceuticals, Filed by: Sagent Pharmaceuticals, Inc.

Aug 9, 2016 10:41 AM Form SC TO-T/A Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Aug 9, 2016 09:25 AM Nichi-Iko Pharmaceutical Co., Ltd. Announces Expiration of HSR Waiting Period for Proposed Acquisition of Sagent Pharmaceuticals, Inc.

Aug 5, 2016 05:17 PM Form 4 Sagent Pharmaceuticals, For: Aug 03 Filed by: OBERMAN ALLAN

Aug 5, 2016 04:23 PM Form 10-Q Sagent Pharmaceuticals, For: Jun 30

Aug 2, 2016 02:24 PM Form SC TO-T/A Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Aug 1, 2016 09:55 AM Shepard Vision, Inc., a Wholly-Owned Subsidiary of Nichi-Iko Pharmaceutical Co., Ltd, Commences All-Cash Tender Offer of $21.75 Net Per Share to Acquire All Outstanding Shares of Sagent Pharmaceutical

Aug 1, 2016 06:16 AM Form SC 14D9 Sagent Pharmaceuticals, Filed by: Sagent Pharmaceuticals, Inc.

Aug 1, 2016 06:11 AM Form SC TO-T Sagent Pharmaceuticals, Filed by: Shepard Vision, Inc.

Jul 28, 2016 09:12 AM Sapiens Names Andre M. Boisvert Chairman of Sapiens DECISION Board of Directors

Jul 18, 2016 08:24 AM Sagent Pharmaceuticals (SGNT) Launches Amikacin Sulfate Injection, USP